NMR studies of models having the Pt(d(GpG)) 17-membered macrocyclic ring formed in DNA by platinum anticancer drugs: Pt complexes with bulky chiral diamine ligands.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Inorganic Chemistry

• Publication date

  2011-04-21

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/ic200259sPMID 21510625
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Basic coordination chemistry relevant to DNA adducts formed by the cisplatin anticancer drug. NMR studies on compounds with sterically crowded chiral ligands.

  2010cited by this paper
• Polymeric drug delivery of platinum-based anticancer agents.

  2009cited by this paper
• Origins of the distortions in the base pair step adjacent to platinum anticancer drug-DNA adducts. Fundamental NMR solution studies utilizing right-handed cross-link models having 5'- and 3'-flanking residues.

  2009cited by this paper
• Platinum drug distribution in cancer cells and tumors.

  2009cited by this paper
• Platinum Anticancer Coordination Compounds: Study of DNA Binding Inspires New Drug Design

  2009cited by this paper
• Mechanistic insight into the cellular uptake and processing of cisplatin 30 years after its approval by FDA

  2009cited by this paper
• A 1,2-d(GpG) cisplatin intrastrand cross-link influences the rotational and translational setting of DNA in nucleosomes.

  2008cited by this paper
• Trend in cytotoxic activity of a series of cis-[APtCl2] (A = ethylenediamine methylated at different positions) complexes

  2008cited by this paper
• Antitumour metal compounds: more than theme and variations.

  2008cited by this paper
• cis-Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects

  2008cited by this paper
• Unique properties of DNA interstrand cross-links of antitumor oxaliplatin and the effect of chirality of the carrier ligand.

  2008cited by this paper
• Conformation of DNA GG intrastrand cross-link of antitumor oxaliplatin and its enantiomeric analog.

  2007cited by this paper
• The resurgence of platinum-based cancer chemotherapy

  2007cited by this paper
• Cisplatin : chemistry and biochemistry of a leading anticancer drug

  2006cited by this paper
• Non-covalent interactions in adducts of platinum drugs with nucleobases in nucleotides and DNA as revealed by using chiral substrates

  2006cited by this paper
• Cellular processing of platinum anticancer drugs

  2005cited by this paper
• Marked dependence on carrier-ligand bulk but not on carrier-ligand chirality of the duplex versus single-strand forms of a DNA oligonucleotide with a series of G-Pt(II)-G intrastrand cross-links modeling cisplatin-DNA adducts.

  2005cited by this paper
• Cisplatin carbonato complexes. Implications for uptake, antitumor properties, and toxicity.

  2005cited by this paper
• Exploring the universality of unusual conformations of the 17-membered Pt(d(G*pG*)) macrochelate ring. Dependence of conformer formation on a change in bidentate carrier ligand from an sp3 to an sp2 nitrogen donor.

  2005cited by this paper
• Platinum-based chemotherapy in metastatic breast cancer: current status.

  2004cited by this paper
• Protein interactions with platinum-DNA adducts: from structure to function.

  2004cited by this paper
• X-ray structure and circular dichroism of pure rotamers of bis[guanosine-5'-monophosphate(-1)](N,N,N',N'-tetramethylcyclohexyl-1,2-diamine)platinum(II) complexes that have R,R and S,S configurations at the asymmetric diamine.

  2003cited by this paper
• Modification of second-sphere communication, leading to an unusually high abundance of the head-to-head conformer of cisplatin cross-link retro models.

  2002cited by this paper
• Chiral discrimination in platinum anticancer drugs.

  2002cited by this paper
• Factors influencing conformer equilibria in retro models of cisplatin-DNA adducts as revealed by moderately dynamic (N,N'-dimethyl-2,3-diaminobutane)PtG(2) retro models (G = a guanine derivative).

  2002cited by this paper
• Dramatic 5'-residue effect on conformer distribution of short oligonucleotide retro models of the cisplatin-DNA cross-link: implications for the Lippard and cross-link distorted base pair steps present in cisplatin-DNA duplex adducts.

  2002cited by this paper
• Cisplatin-DNA cross-link retro models with a chirality-neutral carrier ligand: evidence for the importance of "second-sphere communication".

  2001cited by this paper
• Relationship of solution and protein-bound structures of DNA duplexes with the major intrastrand cross-link lesions formed on cisplatin binding to DNA.

  2001cited by this paper
• cis-Pt(NH3)2(GpG) Properties Interpreted through Comparison with Retro-Model GpG Adducts Having Carrier Ligands Designed to Slow Dynamic Motion and Control Cross-Link Handedness

  2000cited by this paper
• Influence of carrier ligand NH hydrogen bonding to the O6 and phosphate group of guanine nucleotides in platinum complexes with a single guanine ligand.

  2000cited by this paper
• Cisplatin--DNA cross-link models with an unusual type of chirality-neutral chelate amine carrier ligand, N,N dimethylpiperazine (Me2ppz): Me2ppzPt(guanosine monophosphate)2 adducts that exhibit novel properties.

  2000cited by this paper
• Asymmetrical complexes [Pt(N,N-dmen)(dGuo)L](2)+ (N,N-dmen=N,N-dimethylethylenediamine; L=H2O, Cl−, dGuo): H8 nuclei experience an orientation-dependent deshielding effect attributable to the paramagnetic anisotropy of the platinum atom

  2000cited by this paper
• Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins

  1999cited by this paper
• Retro Models of Pt Anticancer Drug DNA Adducts: Chirality-Controlling Chelate Ligand Restriction of Guanine Dynamic Motion in (2,2'-Bipiperidine)PtG(2) Complexes (G = Guanine Derivative).

  1999cited by this paper
• New Concepts Relevant to Cisplatin Anticancer Activity from Unique Spectral Features Providing Evidence That Adjacent Guanines in d(GpG), Intrastrand-Cross-Linked at N7 by a cis-Platinum(II) Moiety, Can Adopt a Head-to-Tail Arrangement

  1999cited by this paper
• A Novel Head-to-Head Conformer of d(GpG) Cross-linked by Pt: New Light on the Conformation of Such Cross-links Formed by Pt Anticancer Drugs

  1998cited by this paper
• Chirality-Controlling Chelate (CCC) Ligands in Analogues of Platinum Anticancer Agents. Influence of N9 Substituents of Guanine Derivatives (G) on the Distribution of Chiral Conformers of (CCC)PtG(2) with CCC = N,N'-Dimethyl-2,3-diaminobutane.

  1998cited by this paper
• The influence of structure on the activity and toxicity of Pt anti-cancer drugs

  1997cited by this paper
• Viewing Early Stages of Guanine Nucleotide Attack on Pt(II) Complexes Designed with In-Plane Bulk to Trap Initial Adducts. Relevance to cis-Type Pt(II) Anticancer Drugs

  1997cited by this paper
• Cisplatin and derived anticancer drugs: mechanism and current status of DNA binding.

  1996cited by this paper
• Site-specific d(GpG) intrastrand cross-links formed by dinuclear platinum complexes. Bending and NMR studies.

  1996cited by this paper
• NMRPipe: A multidimensional spectral processing system based on UNIX pipes

  1995cited by this paper
• Structure and isomerization of an intrastrand cisplatin-cross-linked octamer DNA duplex by NMR analysis.

  1995cited by this paper
• NMR View: A computer program for the visualization and analysis of NMR data

  1994cited by this paper
• DNA Adduct Formation by Platinum Anticancer Drugs. Insight into an Unusual GpG Intrastrand Cross-Link in a Hairpin-like DNA Oligonucleotide Using NMR and Distance Geometry Methods

  1994cited by this paper
• ATROPISOMERIZATION OF CIS-BIS(5'GMP)-PLATINUM(II)-DIAMINE COMPLEXES WITH NON-C2-SYMMETRICAL ASYMMETRIC DIAMINE LIGANDS CONTAINING NH GROUPS DIRECTED T O ONE SIDE OF THE COORDINATION PLANE

  1994cited by this paper
• [1H, 15N] NMR Investigations of Pt-NH Hydrogen Bonding in d(GpG), d(pGpG), and d(TpGpG)-N7,N7 Adducts of [Pt(en)]2+ in Aqueous Solution

  1994cited by this paper
• Reactions of unsymmetrically substituted derivatives of cisplatin with short oligodeoxynucleotides containing a -GpG- sequence: H-bonding interactions in pGpG moieties cross-linked by an asymmetric platinum complex enhancing the formation of one geometrical isomer

  1992cited by this paper
• H8 chemical shifts in oligonucleotide cross-linked at a GpG sequence by cis-Pt(NH3)2(2+): a clue to the adduct structure.

  1992cited by this paper
• Heteronuclear carbon-13-proton NMR investigation of the effects on an oligodeoxyribonucleotide of intrastrand cross-linking by a platinum anticancer drug; a large shift of C3' accompanies an S to N conformational change

  1991cited by this paper
• Multinuclear nuclear magnetic resonance studies of Na cation-stabilized complex formed by d(G-G-T-T-T-T-C-G-G) in solution. Implications for G-tetrad structures.

  1991cited by this paper
• Interaction of bis(platinum) complexes with the mononucleotide 5'-guanosine monophosphate. Effect of diamine linker and the nature of the bis(platinum) complex on product formation

  1991cited by this paper
• Platinum-195 NMR kinetic and mechanistic studies of cis- and trans-diamminedichloroplatinum(II) binding to DNA

  1990cited by this paper
• Stereochemically controlled ligands influence atropisomerization of platinum(II) nucleotide complexes. Evidence for head-to-head and stable .LAMBDA. head-to-tail atropisomers

  1990cited by this paper
• The coordination chemistry of platinum anticancer drugs and related compounds with DNA

  1990cited by this paper
• Cytotoxicity of asymmetric platinum complexes against L-1210 cells. Effect of bulky substituents.

  1990cited by this paper
• The crystal structures of four models for the binding to DNA of cisplatinum derivatives containing a bidentate tertiary diamine

  1988cited by this paper
• NMR of proteins and nucleic acids

  1988cited by this paper
• Crystal and molecular structure of cis-[Pt(NH3)2{d(pGpG)}], the principal adduct formed by cis-diamminedichloroplatinum(II) with DNA

  1988cited by this paper
• The antitumor drug cis-diamminedichloroplatinum(II) preferentially chelating neighboring guanines in the trinucleotide d(pGpGpG)

  1987cited by this paper
• Structural aspects of platinum anticancer drug interactions with DNA

  1987cited by this paper
• First definitive demonstration of ortho shielding effects on platinum-195 NMR signals. Dependence of shift on heterocyclic ligand basicity and ortho substituents in four series of complexes with chloro, dimethyl sulfoxide, and pyridine ligands

  1986cited by this paper
• Diastereotopic exchange in the square-planar platinum(II) complex, (N,N\'-dimethylethylenediamine)bis(guanosine)platinum(II)

  1985cited by this paper
• X-ray structure of the major adduct of the anticancer drug cisplatin with DNA: cis-[Pt(NH3)2(d(pGpG))].

  1985cited by this paper
• Interaction of platinum antitumor agents with guanine nucleosides and nucleotides. Platinum-195 and proton NMR spectroscopic characterization of compound III

  1985cited by this paper
• A 1H and 31P NMR study of cis-Pt(NH3)2[d(CpGpG)-N7(2),N7(3)]. The influence of a 5'-terminal cytosine, on the structure of the cis-Pt(NH3)2[d(GpG)-N7,N7] intrastrand cross-link.

  1985cited by this paper
• Reaction products of cis-diammineplatinum(II) compounds with 5'-guanosine monophosphate characterized by high-frequency proton NMR

  1984cited by this paper
• Principles of Nucleic Acid Structure

  1983cited by this paper
• Conformational analysis of the adduct cis-[Pt(NH3)2 d(GpG)]+ in aqueous solution. A high field (500-300 MHz) nuclear magnetic resonance investigation.

  1982cited by this paper
• Right-handed and left-handed DNA: studies of B- and Z-DNA by using proton nuclear Overhauser effect and P NMR.

  1982cited by this paper
• Interaction of cis-[Pt(NH3)2(H2O)2](NO3)2 with ribose deoxyribose diguanosine phosphates.

  1982cited by this paper
• Evidence for diastereomers of the [platinum(N,N,N',N'-tetramethylethylenediamine)(guanosine)2]2+ cation

  1979cited by this paper
• Carbon‐13 magnetic resonance studies of cyclic compounds. 2. Carbon‐13 chemical shift parameters for equatorial and axial substituents in cyclohexane: The substituents methyl, ethyl, isopropyl, methoxy and phthalimido

  1979cited by this paper

• An Overview of Altered Pathways Associated with Sensitivity to Platinum-Based Chemotherapy in Neuroendocrine Tumors: Strengths and Prospects

  2024cites this paper
• Identification and Characterization of DNA-Oxaliplatin Adducts through α-hemolysin Nanopores.

  2023cites this paper
• Response of Cisplatin Resistant Skov-3 Cells to [Pt(O,O′-Acac)(γ-Acac)(DMS)] Treatment Revealed by a Metabolomic 1H-NMR Study

  2018cites this paper
• A Very Rare Example of a Structurally Characterized 3'-GMP Metal Complex. NMR and Synthetic Assessment of Adducts Formed by Guanine Derivatives with [Pt(Ltri)Cl]Cl Complexes with an N,N',N″ Tridentate Ligand (Ltri) Terminated by Imidazole Rings.

  2017cites this paper
• Pauling Electronegativity On/Off Effects Assessed by 13 C and 29 Si NMR Spectroscopic Analysis.

  2017cites this paper
• NMR effective radius of hydrogen in XIV group hydrides evaluated by NMR spectroscopy.

  2017cites this paper
• Synthesis and Characterization of Pt(II) Complexes with Pyridyl Ligands: Elongated Octahedral Ion Pairs and Other Factors Influencing 1H NMR Spectra.

  2017cites this paper
• N7-platinated ribonucleotides are not incorporated by RNA polymerases. New perspectives for a rational design of platinum antitumor drugs.

  2016cites this paper
• Structural study on the interactions of oxaliplatin and linear DNA.

  2016cites this paper
• Platinated Nucleotides are Substrates for the Human Mitochondrial Deoxynucleotide Carrier (DNC) and DNA Polymerase γ: Relevance for the Development of New Platinum-Based Drugs.

  2016cites this paper
• Adsorption of the cis-[Pt(NH3)2(P2O7)](2-) (phosphaplatin) on hydroxyapatite nanocrystals as a smart way to selectively release activated cis-[Pt(NH3)2Cl2] (cisplatin) in tumor tissues.

  2016cites this paper
• Synthesis and characterization of water-soluble, heteronuclear ruthenium(III)/ferrocene complexes and their interactions with biomolecules.

  2015cites this paper
• Study on the interactions between anti-cancer drug oxaliplatin and DNA by atomic force microscopy.

  2015cites this paper
• DNA fragment conformations in adducts with Kiteplatin.

  2015cites this paper
• General cooperative effects of single atom ligands on a metal: a (195)Pt NMR chemical shift as a function of coordinated halido ligands' ionic radii overall sum.

  2015cites this paper
• Transport of platinum bonded nucleotides into proteoliposomes, mediated by Drosophila melanogaster thiamine pyrophosphate carrier protein (DmTpc1).

  2014cites this paper
• Reactivity of [PtCl(η2-C2H4)(N-N)]+, N-N = diimine ligand, with phenol derivatives and first comparison between single crystal X-ray structures of syn- and anti-[Pt(N-N)(phenolate)2] rotamers in the solid state

  2014cites this paper
• trans-thionate derivatives of Pt(II) and Pd(II) with water-soluble phosphane PTA and DAPTA ligands: antiproliferative activity against human ovarian cancer cell lines.

  2013cites this paper
• Guanine nucleobase adducts formed by [Pt(di-(2-picolyl)amine)Cl]Cl: evidence that a tridentate ligand with only in-plane bulk can slow guanine base rotation.

  2012cites this paper
• Single-stranded oligonucleotide adducts formed by Pt complexes favoring left-handed base canting: steric effect of flanking residues and relevance to DNA adducts formed by Pt anticancer drugs.

  2011cites this paper
• Formation of sequence-independent Z-DNA induced by a ruthenium complex at low salt concentrations.

  2011cites this paper
• Investigation relevant to the conformation of the 17-membered Pt(d(GpG)) macrocyclic ring formed by Pt anticancer drugs with DNA: Pt complexes with a Goldilocks carrier ligand.

  2011cites this paper